| Casgevy |
Human |
exagamglogene autotemcel |
Exagamglogene autotemcel |
EMEA/H/C/005763 |
Vertex Pharmaceuticals (Ireland) Limited |
2024/02/09
|
Authorised |
| Mevlyq |
Human |
eribulin |
Eribulin mesylate |
EMEA/H/C/006134 |
YES Pharmaceutical Development Services GmbH |
2024/02/09
|
Authorised |
| Omjjara |
Human |
momelotinib |
Momelotinib dihydrochloride monohydrate |
EMEA/H/C/005768 |
GlaxoSmithKline Trading Services Limited |
2024/01/25
|
Authorised |
| Uzpruvo |
Human |
ustekinumab |
ustekinumab |
EMEA/H/C/006101 |
Stada Arzneimittel AG |
2024/01/05
|
Authorised |
| Rystiggo |
Human |
rozanolixizumab |
rozanolixizumab |
EMEA/H/C/005824 |
UCB Pharma |
2024/01/05
|
Authorised |
| Rimmyrah |
Human |
ranibizumab |
ranibizumab |
EMEA/H/C/006055 |
Qilu Pharma Spain S.L. |
2024/01/05
|
Authorised |
| Azacitidine Kabi |
Human |
azacitidine |
azacitidine |
EMEA/H/C/006154 |
Fresenius Kabi Deutschland GmbH |
2024/01/05
|
Authorised |
| Krazati |
Human |
adagrasib |
adagrasib |
EMEA/H/C/006013 |
Bristol-Myers Squibb Pharma EEIG |
2024/01/05
|
Authorised |
| Spexotras |
Human |
trametinib |
trametinib dimethyl sulfoxide |
EMEA/H/C/005886 |
Novartis Europharm Limited |
2024/01/05
|
Authorised |
| Naveruclif |
Human |
paclitaxel |
paclitaxel |
EMEA/H/C/006173 |
Accord Healthcare S.L.U. |
2024/01/05
|
Authorised |
| Rezzayo |
Human |
rezafungin |
rezafungin |
EMEA/H/C/005900 |
Mundipharma GmbH |
2023/12/22
|
Authorised |
| Loargys |
Human |
pegzilarginase |
Pegzilarginase |
EMEA/H/C/005484 |
Immedica Pharma AB |
2023/12/15
|
Authorised |
| Agamree |
Human |
vamorolone |
vamorolone |
EMEA/H/C/005679 |
Santhera Pharmaceuticals (Deutschland) GmbH |
2023/12/14
|
Authorised |
| Elrexfio |
Human |
elranatamab |
elranatamab |
EMEA/H/C/005908 |
Pfizer Europe MA EEIG |
2023/12/07
|
Authorised |
| Elucirem |
Human |
gadopiclenol |
Gadopiclenol |
EMEA/H/C/005626 |
Guerbet |
2023/12/07
|
Authorised |
| Vueway |
Human |
gadopiclenol |
Gadopiclenol |
EMEA/H/C/006172 |
Bracco Imaging S.p.A. |
2023/12/07
|
Authorised |
| Veoza |
Human |
fezolinetant |
fezolinetant |
EMEA/H/C/005851 |
Astellas Pharma Europe B.V. |
2023/12/07
|
Authorised |
| Zilbrysq |
Human |
zilucoplan |
zilucoplan |
EMEA/H/C/005450 |
UCB Pharma S.A. |
2023/12/01
|
Authorised |
| Pylclari |
Human |
piflufolastat (18F) |
Piflufolastat (18F) |
EMEA/H/C/005520 |
Curium Pet France |
2023/11/27
|
Authorised |
| Yorvipath |
Human |
palopegteriparatide |
palopegteriparatide |
EMEA/H/C/005934 |
Ascendis Pharma Bone Diseases A/S |
2023/11/17
|
Authorised |